VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 60 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,800 | -26.2% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $10,575 | -26.1% | 7,500 | -16.7% | 0.00% | -33.3% |
| Q1 2023 | $14,310 | -44.0% | 9,000 | -48.6% | 0.00% | -50.0% |
| Q4 2022 | $25,550 | -71.0% | 17,500 | -14.6% | 0.01% | -75.0% |
| Q3 2022 | $88,000 | +10.0% | 20,500 | 0.0% | 0.02% | +14.3% |
| Q2 2022 | $80,000 | -18.4% | 20,500 | 0.0% | 0.02% | -4.5% |
| Q1 2022 | $98,000 | +30.7% | 20,500 | 0.0% | 0.02% | +46.7% |
| Q4 2021 | $75,000 | -50.0% | 20,500 | +9.3% | 0.02% | -53.1% |
| Q3 2021 | $150,000 | +2400.0% | 18,750 | +3650.0% | 0.03% | +3100.0% |
| Q2 2021 | $6,000 | -33.3% | 500 | -50.0% | 0.00% | -50.0% |
| Q1 2021 | $9,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $1,120,000 | 0.80% |
| Samsara BioCapital, LLC | 689,709 | $2,676,000 | 0.71% |
| BVF INC/IL | 3,614,662 | $14,025,000 | 0.68% |
| HAMILTON LANE ADVISORS LLC | 71,491 | $277,000 | 0.11% |
| MAI Capital Management | 647,950 | $2,514,000 | 0.05% |
| Laurion Capital Management LP | 698,000 | $2,708,000 | 0.04% |
| Jasper Ridge Partners, L.P. | 92,939 | $361,000 | 0.02% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,500 | $80,000 | 0.02% |
| Ergoteles LLC | 155,562 | $604,000 | 0.02% |
| Clear Harbor Asset Management, LLC | 25,000 | $97,000 | 0.01% |